To investigate the impact of enhanced AGR2 expression on the extracellular milieu of CMT cells, we conducted immunoblotting to assess AGR2 expression status in CMT cell lines: CMT-U27, CMT-U27e, CF41.Mg, and DMGT. The gene discussed is AGR2; the disease is Charcot-Marie-Tooth disease.